<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Orthotopic Models (7)

Next Generation Syngeneic Models: Top 14 Questions

4 minute read

Next Generation Syngeneic Models: Top 14 Questions

October 2, 2021

Accelerating Cancer Drug Discovery with Digital Pathology-Based Biomarker Analysis

7 minute read

Accelerating Cancer Drug Discovery with Digital Pathology-Based Biomarker Analysis

September 14, 2021

In vivo preclinical models for immune-mediated inflammatory disease drug development

10 minute read

In vivo preclinical models for immune-mediated inflammatory disease drug development

August 2, 2021

Preclinical Models for Bispecific T Cell Engager Development

4 minute read

Preclinical Models for Bispecific T Cell Engager Development

July 5, 2021

Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development

4 minute read

Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development

March 1, 2021

Factors to Consider When Selecting a Next Generation Sequencing (NGS) Technology

6 minute read

Factors to Consider When Selecting a Next Generation Sequencing (NGS) Technology

December 18, 2020

Germ-Free or Antibiotic-Treated Mice? Which Model for Studying the Role of the Gut Microbiota in Preclinical Studies

4 minute read

Germ-Free or Antibiotic-Treated Mice? Which Model for Studying the Role of the Gut Microbiota in Preclinical Studies

December 16, 2020

The Latest Developments on PARP Inhibitors for Prostate Cancer Treatment

6 minute read

The Latest Developments on PARP Inhibitors for Prostate Cancer Treatment

December 3, 2020

The Rising Importance of GITR Agonists as Alternative I/O Candidates for Combination Drug Strategies

6 minute read

The Rising Importance of GITR Agonists as Alternative I/O Candidates for Combination Drug Strategies

November 30, 2020

SHP2 and SOS1 Targets: Additional Players in the KRAS Inhibitors Race?

6 minute read

SHP2 and SOS1 Targets: Additional Players in the KRAS Inhibitors Race?

November 10, 2020